Semaglutide vs Ozempic vs Wegovy: What's the Difference?

If you’ve researched semaglutide, Ozempic, and Wegovy, you’ve probably noticed the names get used interchangeably — and contradictorily. One article treats them as the same thing; the next compares them as rivals. So which is it?

The confusion clears up the moment you understand one distinction. Here’s the difference between semaglutide, Ozempic, and Wegovy — and why it matters for what you ask your provider.

---

The One Distinction That Clears Up Everything

Semaglutide is a drug. Ozempic and Wegovy are brand names for that drug.

That’s the whole thing. Semaglutide is the active ingredient — the actual molecule that does the work. Ozempic® and Wegovy® are both products made by Novo Nordisk, and both contain semaglutide as their active ingredient. They are not three different medications. They are one medication and two of its brand names.

It’s the same relationship as “ibuprofen” versus “Advil” and “Motrin.” Ibuprofen is the drug; Advil and Motrin are brands of it. Asking “semaglutide vs Ozempic” is a little like asking “ibuprofen vs Advil” — they aren’t opponents, one is inside the other.

	Semaglutide	Ozempic®	Wegovy®	Compounded semaglutide
What it is	The active drug (molecule)	Brand name	Brand name	Non-FDA-approved preparation
Maker	N/A (generic name)	Novo Nordisk	Novo Nordisk	Licensed compounding pharmacies
FDA-approved for	N/A	Type 2 diabetes	Chronic weight management	Not FDA-approved
Max dose	N/A	2.0mg weekly	2.4mg weekly	Set by prescribing provider
Active ingredient	—	Semaglutide	Semaglutide	Semaglutide

---

Is Semaglutide the Same as a GLP-1 Medication?

Almost — but it’s worth being precise.

GLP-1 stands for glucagon-like peptide-1, a hormone your gut releases after eating. A “GLP-1 medication” (more precisely, a GLP-1 receptor agonist) is any drug that mimics that hormone. That’s a class of medications, not a single drug.

Semaglutide is one specific member of that class. Others include liraglutide (Saxenda, Victoza) and dulaglutide (Trulicity). Tirzepatide (Mounjaro, Zepbound) is closely related but technically a dual agonist — it mimics GLP-1 and a second hormone, GIP.

So: every semaglutide product is a GLP-1 medication, but not every GLP-1 medication is semaglutide. When someone says “I’m on a GLP-1,” semaglutide is the most likely answer — but it’s the category, not the specific drug. For how the class works biologically, see how GLP-1 medications work.

---

Ozempic vs Wegovy: Same Drug, Different Job

If Ozempic and Wegovy both contain semaglutide, why are there two products?

They were approved for different uses, at different doses.

• Ozempic was approved first, to treat type 2 diabetes. Its weekly dose tops out at 2.0mg. Because it lowers blood sugar and also tends to reduce weight, providers began prescribing it off-label for weight loss — which is part of why the name became famous.
• Wegovy is the version Novo Nordisk brought to market specifically for chronic weight management in people with obesity or excess weight plus a related condition. It’s dosed slightly higher, up to 2.4mg weekly.

Same molecule, different packaging, different FDA-approved indication, slightly different maximum dose. For a closer head-to-head, see Ozempic vs Wegovy.

---

Where Compounded Semaglutide Fits

Here’s the piece most comparison articles skip. Brand-name Ozempic and Wegovy are expensive — often $900–$1,700 per month without insurance — and insurance frequently won’t cover them for weight loss.

Compounded semaglutide is a different route to the same active ingredient. It’s prepared by state-licensed US compounding pharmacies under an individual prescription from a licensed provider. It contains the same semaglutide molecule found in Ozempic and Wegovy.

What it is not: it is not a generic version of Ozempic or Wegovy (true generics don’t exist yet — semaglutide is still under patent), and it is not an FDA-approved finished product. It has not been studied in its own clinical trials. A legitimate telehealth provider should be LegitScript-certified and prescribe only after a real medical review. For the full explanation, see what is compounded semaglutide.

---

So Which One Should You Ask About?

It depends less on the names and more on your situation:

• You have type 2 diabetes and insurance coverage → Ozempic (or another GLP-1) through your regular provider may be straightforward.
• You have obesity-range BMI and insurance that covers weight-loss drugs → Wegovy may be covered after prior authorization.
• You’re paying out of pocket and brand pricing isn’t realistic → compounded semaglutide through a licensed telehealth provider is the route most self-pay patients take.

The active ingredient is the same semaglutide in every case. What differs is the FDA-approval status, the price, and how you access it. A licensed provider can tell you which path fits your medical history and budget.

---

Bottom Line

Semaglutide is the drug. Ozempic and Wegovy are two brand-name products that contain it — Ozempic for diabetes, Wegovy for weight management. All of them are GLP-1 medications. Compounded semaglutide delivers the same active ingredient through a non-FDA-approved preparation that’s far more affordable for self-pay patients.

Once you see that the names describe products and approvals, not different molecules, the whole comparison gets a lot simpler.

REMEVi prescribes compounded semaglutide through licensed US providers, with a bilingual 5-minute intake and clinical review typically within 24 hours. See pricing or get started.

---

This article is for informational purposes only and does not constitute medical advice. Ozempic®, Wegovy®, Mounjaro®, and Zepbound® are registered trademarks of their respective manufacturers, referenced here for identification and comparison only. Compounded semaglutide is a non-FDA-approved preparation and is not a generic version of any branded product. Consult a licensed provider before starting any prescription medication.